Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
The new sharewise is here Clearer, faster, with a light and a dark view — and everything you already know. Try it now
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Avalo Therapeutics Inc. buy Oppenheimer Holdings Inc.

Avalo Therapeutics Inc.
Start price
€0.041
16.04.24 / 50%
Target price
-
16.04.25
Performance (%)
-
End price
-
17.04.25
Summary
This prediction was cancelled by the user.
Performance without dividends (%)
Name 1w 1m 1y
Avalo Therapeutics Inc. - - -
iShares Core DAX® 1,00 % 4,83 % 8,15 %
iShares Nasdaq 100 2,70 % -1,72 % 26,92 %
iShares Nikkei 225® 3,52 % -3,51 % 48,06 %
iShares S&P 500 1,77 % 1,27 % 23,58 %

Comments by Oppenheimer_Holdings for this prediction

In the thread Avalo Therapeutics Inc. diskutieren

Avalo Therapeutics, Inc. (NASDAQ: AVTX) was upgraded by analysts at Oppenheimer Holdings Inc. from a "market perform" rating to an "outperform" rating.
Ratings data for AVTX provided by MarketBeat

Oppenheimer Holdings Inc. 
0
Report Share
16.04.24 Buy -
In the thread Trading Avalo Therapeutics Inc.
Prediction Buy
Perf. (%) -
Target price
Change
Ends at 16.04.25

Die von Oppenheimer_Holdings gewählte maximale Laufzeit wurde überschritten

Oppenheimer Holdings Inc. 
0
Report Share
17.04.25